These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Agrawal A, Sharma BC, Sharma P, Sarin SK. Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579 [Abstract] [Full Text] [Related]
9. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774 [Abstract] [Full Text] [Related]
17. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Luo M, Li L, Lu CZ, Cao WK. Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378 [Abstract] [Full Text] [Related]
19. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy]. Zeng Z, Li YY. Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1126-9. PubMed ID: 12921628 [Abstract] [Full Text] [Related]
20. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy. Saji S, Kumar S, Thomas V. Trop Gastroenterol; 2011 Jul 10; 32(2):128-32. PubMed ID: 21922877 [Abstract] [Full Text] [Related] Page: [Next] [New Search]